Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT05021120
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

Who this might be right for
Advanced or Metastatic Solid Tumours
Akesobio Australia Pty Ltd 67
Testing effectiveness (Phase 2)Looking for participantsNCT05623982
What this trial is testing

GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT05027139
What this trial is testing

Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Who this might be right for
HER2-expressing Cancers
Jazz Pharmaceuticals 52
Early research (Phase 1)UnknownNCT04687423
What this trial is testing

Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II）

Who this might be right for
Advanced Solid Tumor
Fochon Pharmaceuticals, Ltd. 82
Testing effectiveness (Phase 2)Study completedNCT04773782
What this trial is testing

Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Who this might be right for
Solid Tumor, Unspecified, ChildRelapsed Solid NeoplasmCNS Tumor
Blueprint Medicines Corporation 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680569
What this trial is testing

Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma

Who this might be right for
GC/GEJC
Kaohsiung Medical University Chung-Ho Memorial Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06895031
What this trial is testing

Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Solid TumorPancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)+1 more
Guangzhou JOYO Pharma Co., Ltd 210
Early research (Phase 1)Not Yet RecruitingNCT07636707
What this trial is testing

QLF4113 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 140
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Early research (Phase 1)Ended earlyNCT04249843
What this trial is testing

Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors

Who this might be right for
Solid TumorB-Raf Mutation-Related Tumors
MapKure, LLC 109
Testing effectiveness (Phase 2)Study completedNCT06703346
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM CT, LLC 82
Testing effectiveness (Phase 2)Study completedNCT01124435
What this trial is testing

Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

Who this might be right for
Ovarian Neoplasms
Catholic University of the Sacred Heart 45
Early research (Phase 1)Active Not RecruitingNCT06052306
What this trial is testing

Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bayer 232
Early research (Phase 1)Study completedNCT04649385
What this trial is testing

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeiGene 157
Testing effectiveness (Phase 2)Looking for participantsNCT07612891
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)Advanced Solid CancersMetastatic (Stage IV) Breast Cancer+2 more
Shenzhen Ionova Life Sciences Co., Ltd.
Early research (Phase 1)Study completedNCT04215978
What this trial is testing

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma (HNSCC)+1 more
BeiGene 204
Early research (Phase 1)Study completedNCT01248949
What this trial is testing

Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Recurrent Ovarian Tumors
MedImmune LLC 162
Early research (Phase 1)Looking for participantsNCT06944444
What this trial is testing

A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD. 154
Early research (Phase 1)Study completedNCT02991911
What this trial is testing

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
MedImmune LLC 33
Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Next Page
201